GlassScriptPhysician profile
Travis W Bessell
NPI 1447571302
$6,450.01
in general payments reported to CMS, 2019-2025
39 companies · $1,962 in 2025
The $1,962 reported for 2025 was more than what 91% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $749 · 2022: $170 · 2023: $1,751 · 2024: $1,818 · 2025: $1,962.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,433 · Education: $98.90.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,432.61 |
| Education | $98.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,204.59 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $854.66 | 2021-2025 | |
| Abbvie INC. | $807.00 | 2021-2025 | |
| Lilly USA, LLC | $560.99 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Amgen INC. | $486.28 | 2021-2025 | Repatha, Evenity, Otezla |
| Glaxosmithkline, LLC. | $379.00 | 2022-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Astrazeneca Pharmaceuticals LP | $250.42 | 2021-2025 | Farxiga, Airsupra, Breztri |
| Astellas Pharma US INC | $177.16 | 2023-2024 | Veozah |
| Exact Sciences Corporation | $176.22 | 2023-2025 | Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $146.11 | 2021-2024 | Jardiance |
| Lundbeck LLC | $130.20 | 2023-2025 | Rexulti |
| Merck Sharp & Dohme LLC | $123.46 | 2021-2025 | Gardasil 9, Capvaxive, Vaxelis |
| Takeda Pharmaceuticals U.S.A., INC. | $110.43 | 2023-2025 | Trintellix, Glassia |
| Axsome Therapeutics, INC. | $95.88 | 2023-2025 | Auvelity |
| E.R. Squibb & Sons, L.L.C. | $86.55 | 2023-2025 | Eliquis, Camzyos |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Travis Bessell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.